Quincy Bioscience
TINA.org investigated Quincy Bioscience’s marketing of its brain supplement Prevagen, and was involved as amicus curiae in two separate lawsuits filed against the company. To read more about those efforts, click here.
Brands
Featured
Prevagen Memory Study Falls Short
TINA.org, AARP and others file legal brief urging court to reverse dismissal of Prevagen case.
The Latest
Clear-cut fraud? Quincy Bioscience faces a potentially ruinous lawsuit over memory claims
Marc Eisen, Isthmus
Marketers exploit the aged with unproven brain-health claims
Rick Schmitt, Newsweek
Memory supplement from jellyfish doesn’t work, FTC says
Herb Weisbaum, Komo News
Prevagen’s Fishy Memory Claims Under Fire by Federal Regulators
Five things you should know about the FTC, New York lawsuit against Prevagen.
Which of these Products are April Fools?
Take this quiz to test your buyer beware prowess.
Ad Watchdog Calls Out Broadcast Networks for Airing Deceptive Ads
TINA.org Urges Better Screening MADISON, CONN., January 19, 2016 – Consumer advocacy organization, truthinadvertising.org (TINA.org), has put major broadcast networks on notice regarding deceptive advertising. The ad watchdog alerted ABC,…
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
TINA.org also calls on the BBB to re-evaluate company’s A+ rating.
Deceptive Ads 2015
FTC Complaint Filed Against Maker of Memory Supplement
Ad Watchdog Issues Warning to Consumers MADISON, CONN. September 21, 2015 — With an aging baby-boomer population and an estimated 10 million Americans predicted to develop some form of brain…
TINA.org to FTC: Prevagen is Making Unsupported Memory Claims
Investigation finds no competent evidence to support memory improvement claims and FTC files a lawsuit.
Class-Action Tracker
Prevagen Dietary Supplements
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Quincy Bioscience’s Prevagen
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Prevagen Supplement
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Prevagen Products
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Quincy Bioscience’s Prevagen Supplement
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Prevagen Dietary Supplement
December 2020: The appeal was dismissed because the appellant failed to pay filing and docketing fees. November 2020: A federal judge granted final approval of the settlement agreement. Later in…
Prevagen Supplements
A false advertising class-action lawsuit against Quincy Bioscience was dismissed in June 2016. The complaint, which was originally filed in state court in March 2015 and transferred to federal court…